SOMINEX MAX STR OTC
Generic Name and Formulations:
Diphenhydramine HCl 50mg; tabs.
Indications for SOMINEX MAX STR:
Short-term (≤ 2 weeks) treatment of insomnia.
50mg at bedtime.
Asthma. Lower respiratory disorders. Glaucoma. Hyperthyroidism. Hypertension. Cardiovascular disease. GI or urinary obstruction. Pregnancy. Nursing mothers.
Potentiates CNS depression with alcohol, other CNS depressants. Concomitant diphenhydramine products (including topicals): not recommended. Additive effects with other other anticholinergics.
Drowsiness, dizziness, anticholinergic effects, paradoxical excitement.
Original (tabs)—16, 32, 72
Max Strength (caplets)—16
Neurology Advisor Articles
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL
- Congress Passes Bill to Fight Opioid Crisis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure